NVCR Novocure Ltd

$14.25 -20.12%

Healthcare · Surgical & Medical Instruments & Apparatus

Novocure Ltd (NVCR) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $1.7 billion. Shares last traded at $14.25, 24.7% below their 52-week high. Over the past year the stock is down 18.2%. Net profit margin is -20.8%, below the peer median of -7.6%. Revenue grew 8.3% year over year.

Market Cap

$1.7B

Shares Out

115.8M

EPS (TTM)

$-3.51

P/E Ratio

—

P/S Ratio

2.52

P/B Ratio

4.99

Dividend / Share

—

Dividend Yield

—

52-Week High

$18.92

52-Week Low

$9.82

Volume

213,931

Avg Vol (3m)

80,700.333

Performance

-19.54%

-16.23%

+14.37%

+10.21%

YTD

+8.70%

-18.20%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

36.85

SMA (50)

$15.62

SMA (200)

$13.37

Price vs SMA50

-8.76%

Price vs SMA200

+6.59%

ATR (14)

$1.29

Financials

Revenue

$655M

Net Income

$-136M

Gross Margin

74.5%

Operating Margin

-23.5%

Net Margin

-20.8%

Return on Equity

-41.2%

Return on Assets

-17.3%

Current Ratio

2.90

Debt / Equity

0.59

Revenue Growth (YoY)

+8.3%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.62	2026-04-30
Q1 2026	$-1.22	2026-04-30
Q3 2025	$-1.00	2025-10-30
Q2 2025	$-0.67	2025-07-24
Q1 2026	$-0.31	2026-04-30
FY 2025	$-1.56	2026-02-26

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

NVCR vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

2.52 / 2.52 med

+0% premium

Net margin vs peers

-20.8% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.